|
| 5-(4-HEXYLOXY-[1,2,5]THIADIAZOL-3-YL)-1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDINE Basic information |
Product Name: | 5-(4-HEXYLOXY-[1,2,5]THIADIAZOL-3-YL)-1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDINE | Synonyms: | 3-[4-(Hexy loxy)-1,2,5-thiadiazol-3-y1]-1,2,5,6-tetrahydro-1-methylpyridine;5-(4-HEXYLOXY-[1,2,5]THIADIAZOL-3-YL)-1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDINE;Lomeron;LY-246708;Memcor;NNC-11-0232;3-(Hexyloxy)-4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole;Xanomeline L-tartrate hydrate | CAS: | 131986-45-3 | MF: | C14H23N3OS | MW: | 281.42 | EINECS: | | Product Categories: | | Mol File: | 131986-45-3.mol | |
| 5-(4-HEXYLOXY-[1,2,5]THIADIAZOL-3-YL)-1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDINE Chemical Properties |
Boiling point | 397.0±42.0 °C(Predicted) | density | 1.101±0.06 g/cm3(Predicted) | storage temp. | Sealed in dry,2-8°C | solubility | H2O: soluble10mg/mL, clear (warmed) | form | powder | pka | 7.34±0.40(Predicted) | color | off-white | InChIKey | JOLJIIDDOBNFHW-UHFFFAOYSA-N |
| 5-(4-HEXYLOXY-[1,2,5]THIADIAZOL-3-YL)-1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDINE Usage And Synthesis |
Uses | Alzheimer’s disease treatment (cholinergic agonist). | Definition | ChEBI: Xanomeline is a member of thiadiazoles and a tetrahydropyridine. It has a role as a muscarinic agonist and a serotonergic agonist. |
| 5-(4-HEXYLOXY-[1,2,5]THIADIAZOL-3-YL)-1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDINE Preparation Products And Raw materials |
|